MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- IND. SWIFT
IND. SWIFT Share Price (ISWF)
Here is the latest stock price and chart of IND. SWIFT. For more details, see the IND. SWIFT company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since such stocks interest you, here's a proven approach to making penny stock investments.
Act Now: Once-in-a-Century Opportunity
| Live BSE Quotes | Dec 6, 2021 03:36:00 PM | ||
|---|---|---|---|
| Price (Rs)12.30 | Open (Rs) 12.50 | High (Rs) 12.65 | Low (Rs) 12.30 |
| % Change-2.77 | Volume 20,829 | Value (Rs) 256,197 | 52-Week H/L 16.76 / 3.40 |
| Live NSE Quotes | Dec 6, 2021 3:29:54 PM | ||
|---|---|---|---|
| Price (Rs)12.20 | Open (Rs) 13.20 | High (Rs) 13.20 | Low (Rs) 12.15 |
| % Change-4.31 | Volume 58,630 | Value (Rs) 731,116 | 52-Week H/L 16.60 / 3.55 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day -2.77% | 1 Month -2.07% | 3 Months 24.37% | 1 Year 164.52% | 5 Years (CAGR)* 15.44% | 10 Years (CAGR)* -7.35% |
* Compound Annual Growth Rate
| Valuation | ||||
|---|---|---|---|---|
| EPS (Rs)* -5.02 | P/E Ratio (x) NM | Market Cap (Rs m) 666.23 | P/BV (x) -0.10 | Dividend Yield (%) 0.00 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
IND. SWIFT Share Price Today:
IND. SWIFT last traded price was down 2.8% to Rs 12.3 on the BSE. On the NSE, IND. SWIFT last traded price was down 4.3% to Rs 12.2. The total volume of shares traded was 0.1 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.8%. And the benchmark S&P BSE SENSEX was at 56,747.1 (down 1.6%).
Over the last 30 days, the IND. SWIFT share price is up 7.9%. And over the last one year, IND. SWIFT share price is up 188.7%.
The current market capitalisation of IND. SWIFT stands at Rs 666.23 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of September 2021, promoter pledging in IND. SWIFT stands at 73.46%. To know more, check out the latest shareholding pattern of IND. SWIFT.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- Top Gainers Today BSE A Group
- Top Gainers Today NSE Above Rs 20
- Top Gainers Today BSE Above Rs 20
- Top Gainers Today BSE Sensex
- Top Gainers Today BSE Small Cap
- Top Gainers Today BSE 500
- Top Losers Today BSE A Group
- Most Active Stocks Rs 1 to 2
- Top Losers Today NSE Above Rs 20
- Most Popular Stocks BSE 30
- TRENDING ON EQUITYMASTER:
- Warren Buffett - The Value Investor
- Your Ultimate Guide to Penny Stock Investing
- How to Invest in Gold
- Basics of Value Investing
- Benjamin Graham
- The Best Bluechip Stocks to Buy
- How to Invest in Silver
- The Best Small-cap Stocks to Buy
- 10 Rules for Successful Long-Term Investing
- How to Invest in the Share Market
- Best Stocks to Buy Today
- How to Use P/E for Successful Investing
- How to Find Undervalued Stocks
- Differences Between Trading and Investing
- SWOT Analysis for Stocks
- The Best Dividend Stocks to Buy
Today's Market
5 Reasons Why Sensex Slumped 949 Points Today(Closing)
Indian share markets witnessed huge selling pressure today and ended deep in the red.
Related Views On News
5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)
Dec 3, 2021As the new variant of Covid-19 emerges, keep an eye on these stocks.
This Stock Just Made a Historical Debut on the Exchanges (Views On News)
Nov 15, 2021Shares of the company listed at premium of 253% from its IPO price, the highest ever.
3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)
Nov 9, 2021In 2021, R&D of pharma companies roared to life in a never-before-seen way.
Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)
Oct 8, 2021The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.
Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)
Sep 30, 2021The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.
More Views on NewsMost Popular
Infosys vs TCS: Which is Better? (Views On News)
Nov 26, 2021In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.
This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)
Nov 24, 2021Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.
6 Popular Stocks that Turned into Penny Stocks (Views On News)
Nov 27, 2021A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.
India's Top 5 Monopoly Stocks to Watch Out for (Views On News)
Nov 30, 2021These 5 companies dominate their sectors with a huge piece of the pie.
5 Indian Companies Embracing Blockchain Technology (Views On News)
Nov 23, 2021Blockchain adoption in India was slow in the past. Now, the technology is being well received.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2022
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: How to Profit from Sensex 100,000
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK IND. SWIFT
- Track your investment in IND. SWIFT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON IND. SWIFT
IND. SWIFT 8-QTR ANALYSIS
COMPARE IND. SWIFT WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
APP
EQUITYMASTER SUPPORTS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.